{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:37:14Z","timestamp":1780432634868,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Mercer University"},{"name":"Mercer Undergraduate Biomedical Scholar"},{"name":"Landings Women\u2019s Golf Association"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.virol.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T08:25:04Z","timestamp":1547108704000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Identification of the Epstein Barr Virus portal"],"prefix":"10.1016","volume":"529","author":[{"given":"Robert J.","family":"Visalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Visalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2019.01.003_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.copbio.2011.12.023","article-title":"Molecular motors for DNA translocation in prokaryotes","volume":"23","author":"Allemand","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.virol.2019.01.003_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/310207a0","article-title":"DNA sequence and expression of the B95-8 Epstein-Barr virus genome","volume":"310","author":"Baer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.virol.2019.01.003_bib3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/cti.2015.1","article-title":"Infectious mononucleosis","volume":"4","author":"Balfour","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.virol.2019.01.003_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2019.01.003_bib5","doi-asserted-by":"crossref","first-page":"70006","DOI":"10.18632\/oncotarget.19549","article-title":"Characterization of the subcellular localization of Epstein-Barr virus encoded proteins in live cells","volume":"8","author":"Cai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.virol.2019.01.003_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5501\/wjv.v1.i6.154","article-title":"Roles of the PI3K\/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications","volume":"1","author":"Chen","year":"2012","journal-title":"World J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2019.01.003_bib8","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.vaccine.2016.06.021","article-title":"Rabbits immunized with Epstein-Barr virus gH\/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350","volume":"34","author":"Cui","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.01.003_bib9","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/JVI.02254-06","article-title":"Direct visualization of the putative portal in the Kaposi's sarcoma-associated herpesvirus capsid by cryoelectron tomography","volume":"81","author":"Deng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/bi047911w","article-title":"Analysis of the quaternary structure of the putative HCMV portal protein PUL104","volume":"44","author":"Dittmer","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2019.01.003_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.semcancer.2013.07.005","article-title":"Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas","volume":"23","author":"Dolcetti","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.virol.2019.01.003_bib12","first-page":"410","article-title":"Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry","volume":"3","author":"Eiz-Vesper","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2019.01.003_bib13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11899-012-0136-z","article-title":"Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved","volume":"7","author":"George","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.virol.2019.01.003_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jac\/dki240","article-title":"Epstein-Barr virus infections: prospects for treatment","volume":"56","author":"Gershburg","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.virol.2019.01.003_bib16","doi-asserted-by":"crossref","first-page":"e1774","DOI":"10.1038\/cddis.2015.145","article-title":"Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent\/lytic cycle of the virus","volume":"6","author":"Giunco","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.virol.2019.01.003_bib17","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.013292-0","article-title":"Assembly of monomeric human cytomegalovirus pUL104 into portal structures","volume":"90","author":"Holzenburg","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib18","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/rmv.1816","article-title":"Host genetics of Epstein-Barr virus infection, latency and disease","volume":"25","author":"Houldcroft","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virusres.2012.03.013","article-title":"The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54","volume":"167","author":"Howard","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2019.01.003_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11684-016-0436-0","article-title":"Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing","volume":"10","author":"Hu","year":"2016","journal-title":"Front. Med."},{"key":"10.1016\/j.virol.2019.01.003_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/v9110352","article-title":"Therapeutic strategies against epstein-barr virus-associated cancers using proteasome inhibitors","volume":"9","author":"Hui","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2019.01.003_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens5010018","article-title":"The role of gammaherpesviruses in cancer pathogenesis","volume":"5","author":"Jha","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2019.01.003_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11864-013-0231-y","article-title":"EBV-related lymphomas: new approaches to treatment","volume":"14","author":"Kanakry","year":"2013","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.virol.2019.01.003_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.onc.1210240","article-title":"Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions","volume":"26","author":"Klein","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2019.01.003_bib26","doi-asserted-by":"crossref","first-page":"e1972","DOI":"10.1002\/rmv.1972","article-title":"Human herpesvirus portal proteins: structure, function, and antiviral prospects","volume":"28","author":"Kornfeind","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00747-17","article-title":"Drug modulators of B cell signaling pathways and epstein-barr virus lytic activation","volume":"91","author":"Kosowicz","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib28","doi-asserted-by":"crossref","first-page":"31018","DOI":"10.18632\/oncotarget.5041","article-title":"Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.virol.2019.01.003_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.virol.2019.01.003_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12885-016-3027-1","article-title":"Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.virol.2019.01.003_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jmb.2008.02.017","article-title":"Determination of stoichiometry and conformational changes in the first step of the P22 tail assembly","volume":"379","author":"Lorenzen","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2019.01.003_bib32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1006\/jmbi.2001.4800","article-title":"Structural organisation of the head-to-tail interface of a bacterial virus","volume":"310","author":"Lurz","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2019.01.003_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib34","doi-asserted-by":"crossref","first-page":"e2006191","DOI":"10.1371\/journal.pbio.2006191","article-title":"Structure of the herpes simplex virus portal-vertex","volume":"16","author":"McElwee","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.virol.2019.01.003_bib35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2018.00556","article-title":"Adoptive T cell therapy for epstein-barr virus complications in patients with primary immunodeficiency disorders","volume":"9","author":"McLaughlin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2019.01.003_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mib.2006.06.013","article-title":"Herpesvirus assembly: a tale of two membranes","volume":"9","author":"Mettenleiter","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.virol.2019.01.003_bib37","doi-asserted-by":"crossref","first-page":"e1700423","DOI":"10.1126\/sciadv.1700423","article-title":"A viral scaffolding protein triggers portal ring oligomerization and incorporation during procapsid assembly","volume":"3","author":"Motwani","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virol.2019.01.003_bib38","first-page":"v","article-title":"Preface","volume":"390(Pt 1)","author":"M\u00fcnz","year":"2015","journal-title":"Curr.\u00a0Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2019.01.003_bib39","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1128\/JVI.75.22.10923-10932.2001","article-title":"The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid","volume":"75","author":"Newcomb","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virusres.2013.01.021","article-title":"Headful DNA packaging: bacteriophage SPP1 as a model system","volume":"173","author":"Oliveira","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2019.01.003_bib41","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JVI.02533-12","article-title":"An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA","volume":"87","author":"Pavlova","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1574891X09666140828114812","article-title":"Survey of Epstein Barr virus (EBV) immunogenic proteins and their epitopes: implications for vaccine preparation","volume":"9","author":"Rajcani","year":"2014","journal-title":"Recent Pat. anti-Infect. Drug Discov."},{"key":"10.1016\/j.virol.2019.01.003_bib43","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","article-title":"Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)","volume":"93","author":"Russo","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2019.01.003_bib44","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00432-015-1969-3","article-title":"Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma","volume":"141","author":"Stoker","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.virol.2019.01.003_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.01.003","article-title":"Thymidine kinase and protein kinase in drug-resistant herpesviruses: heads of a Lernaean Hydra","volume":"37","author":"Topalis","year":"2018","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.virol.2019.01.003_bib46","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/emm.2014.102","article-title":"Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target","volume":"47","author":"Tse","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.virol.2019.01.003_bib47","article-title":"Epstein\u2013Barr virus: opportunities for prophylactic and therapeutic vaccines","author":"Turner","year":"2013","journal-title":"Micorbiol. Today"},{"key":"10.1016\/j.virol.2019.01.003_bib48","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1128\/JVI.74.19.9054-9061.2000","article-title":"Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene","volume":"74","author":"van Zeijl","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib49","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/JVI.77.4.2349-2358.2003","article-title":"Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication","volume":"77","author":"Visalli","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000360225","article-title":"Non-axial view of the varicella-zoster virus portal protein reveals conserved crown, wing and clip architecture","volume":"57","author":"Visalli","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.virol.2019.01.003_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(03)00108-6","article-title":"DNA encapsidation as a target for anti-herpesvirus drug therapy","volume":"59","author":"Visalli","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.01.003_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/378072","article-title":"Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir","volume":"188","author":"Walling","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2019.01.003_bib53","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1128\/JVI.77.11.6351-6358.2003","article-title":"Herpes simplex virus type 1 portal protein UL6 interacts with the putative terminase subunits UL15 and UL28","volume":"77","author":"White","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib54","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-12-0574","article-title":"Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors","volume":"18","author":"Wildeman","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virol.2019.01.003_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.virol.2019.01.003_bib56","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1128\/JVI.00150-08","article-title":"Domain within herpes simplex virus 1 scaffold proteins required for interaction with portal protein in infected cells and incorporation of the portal vertex into capsids","volume":"82","author":"Yang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.003_bib57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/1348-0421.12507","article-title":"Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54","volume":"61","author":"Yasui","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.virol.2019.01.003_bib58","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/hed.25131","article-title":"Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma","volume":"40","author":"Yu","year":"2018","journal-title":"Head Neck"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219300030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219300030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:49:05Z","timestamp":1758588545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682219300030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":58,"alternative-id":["S0042682219300030"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2019.01.003","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the Epstein Barr Virus portal","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}